Randomized phase Ⅲ study of 5-fluorouracil/folinate/oxaliplatin given continuously or intermittently with or without cetuximab, as first-line treatment of metastatic colorectal cancer: The NORDIC VII study (NCT00145314) , by the Nordic Colorectal Cancer Biomodulation Group

查看全文 作　　者：Tveit K; Guren T; Glimelius B; 出　　处：《J C lin Oncol》索引2011年第29卷第4期,共0页